CD Autism Facts Sheet

This is the home of the CD Autism Facts Sheet, which tries to objectively present known facts about the protocol developed by Kerri Rivera to help children suffering from Autism.

The latest CD Autism Facts Sheet (PDF) is located at the following permanent link:

Please remember to share and distribute only this exact link to insure that everyone has the most current version of this information.

References (Version 18)

Due to space limitations, references to the CD Autism Facts Sheet are located below.  They will be kept up-to-date and in sync with the facts sheet itself.

5. See page 27, Healing the Symptoms Known as Autism, 2nd Ed., by Kerri Rivera.
13. Video Testimonials by parents who have used the CDAutism protocol:
Other testimonials:
20. Ekiel A, Aptekorz M, Kazek B, Wiechuła B, Wilk I, Martirosian G. 2010. Intestinal microflora of autistic children. Med Dosw Mikrobiol. 62:237-243.
21. Kałužna-Czapliñska J, Błaszczyk S. 2012. The level of arabinitol in autistic children after probiotic therapy. Nutrition. 28:124-126. Bransfield RC. 2009.
22. Preventable cases of autism: relationship between chronic infectious diseases and neurological outcome. Pediatric Health. 3(2):125-140
29. The following is taken from Environmentally Benign Approaches for Pulp Bleaching“An industrial oxygen-delignified hardwood (mainly eucalyptus) kraft pulp (HOKP) and partially bleached industrial pulp by D (EO) sequence (HPBKP) were used. The pulps were subjected to chlorine dioxide bleaching in various conditions. In mill A normal HotD stage was carried out with HOPK, while in mill B, modified HotD stage was used. The bleaching condition in the the normal HotD stage was 90° C for 3.2 hr using 10-12 kg chlorine dioxide per o.d. ton of pulp, while bleaching condition in the modified HotD stage was 90° for 3 hr using 5-8kg of chlorine dioxide per o.d. ton of pulp.

Note: Emphasis is the author’s.

Let’s take the lowest figure here to get another perspective: 5kg of chlorine dioxide to bleach one ton of pulp. So to “bleach” an 80kg man you would need to drink .44 kilograms of chlorine dioxide. 440,000 milligrams. A 3-drop dose of CD equals approximately 20mg of chlorine dioxide.  You would need over 22,000 times the amount of chlorine dioxide used in an average dose of chlorine dioxide to actually “bleach,” per the standards commonly used by industry, using the lowest possible amount; 5 kg of CD needed to bleach 1 ton of pulp.

1 ton = 907kg
1 man = 80kg
907/80 = 11.33
5 kilos/11.33 = .44kg
.44kg = 440,000 mg
440,000mg /20mg = 22,000m

A 3-drop dose of CD is approximately 22,000 times weaker than the concentration required by industry to bleach a man’s weight in pulp.

30. A history of Medicine, by Henry Ernest Sigerist, book, Oxford University Press, 1987


100. Patent US5384134
Anti-inflammatory formulations for inflammatory diseases
Inventors: Robert D. Kross & Elliott J. Siff

Publication Date: 1/24/1995
Abstract: There is disclosed a method for treating dermatologic diseases caused by microbial overgrowth or inflammation, such as psoriasis, fungal infections, eczema, dandruff, acne, genital herpes lesions, and leg ulcers. There is further disclosed an antiviral lubricating composition that is effective in preventing the transmission of the HIV virus and other sexually transmitted diseases. There is also disclosed systemic anti-inflammatory compositions and formulations and a method for reducing tissue inflammation in tissues such as the bowel, muscle, bone, tendon and joints (e.g., arthritis).
101. Patent US4689215
Method and composition for prevention and treatment of oral disease
Inventor:  Perry A. Ratcliff

Publication Date:  8/25/1987
Abstract: The use of stabilized chlorine dioxide as a composition for the treatment and prevention of oral disease and the reduction of oral malodor is disclosed. Chlorine dioxide is an effective anti-plaque agent, anti-gingivitis and anti-periodontitis agent, and also effective to destroy malodorous sulfur compounds. Preferred concentrations are in the range of 0.005% to 2% and the chlorine dioxide may be in the form of a wash or rinse in solution, a soak or as a toothpaste.
102. Patent US4507285
Stabilized activated oxygen and pharmaceutical compositions containing said stabilized activated oxygen
Inventor:  Friedrich-Wilhelm Kuhne
Publication Date:  3/26/1985
Abstract:  The invention provides a stabilized activated oxygen in matrix of chlorite ions and pharmaceutical compositions containing this stabilized activated oxygen. The stabilized activated oxygen is present in the form of a solution. The medication can be used for the treatment of skin diseases or wound healing disorders.
103. Patent US4296102
Administering perborate-stabilized chlorine oxides
Inventor:  Felipe Laso
Publication Date:  10/20/1981
Abstract:  A method for combating amebiasis in humans comprising orally administering to said humans an effective amount of a perborate-stabilized aqueous solution of chlorine oxides, said solution containing about 4-12% by weight of sodium or potassium perborate and a peroxide or percarbonate.
104. Patent US5019402
Composition and procedure for disinfecting blood and blood components
Inventors:  Robert D. Kross & David I. Scheer
Publication Date:  5/28/1991
Abstract:  There is disclosed a composition and process for disinfecting or essentially sterilizing blood fractions and components of blood. The composition is formed by adding a chlorine dioxide liberating compound with a weak organic acid and a heat activated saccharide.
105. Patent US4851222
Method of promoting regeneration of bone marrow
Inventors:  Friedrich W. Kuhne & Stanislav Ivankovic
Publication Date:  7/25/1989
Abstract:  In a process for promoting regenerating of bone marrow there is administered to a mammal in need thereof an effective regeneration promoting dose of an aqueous solution of stabilized oxygen in a matrix of chlorite ions.
106. Patent US8029826
Chlorite in the treatment of neurodegenerative disease
Inventor:  Michael S. McGrath
Publication Date:  10/4/2011
Abstract:  The invention features methods of treating a macrophage-associated neurodegenerative disease such as amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), or multiple sclerosis (MS) in a subject by administering chlorite in an amount effective to decrease blood immune cell activation. The invention also features methods of monitoring therapy by assessing blood immune cell activation before and after therapy.
107. Patent EP2429308
Chlorine dioxide based gum and candy
Inventors:  Heinz Peter Plaumann & Christopher R. Castellano
Publication Date:  3/21/2012
Abstract:  Provided are oral compositions and devices comprising an active agent that is one of chlorine dioxide-generating components, a chlorine dioxide-containing solution, and combinations thereof.
108. Patent US6086922
Use of a chemically-stabilized chlorite matrix for the parenteral treatment of HIV infections
Inventor:  Friedrich W. Kuhne
Publication Date:  7/11/2000
Abstract:  The present invention is concerned with the use of a chemically-stabilized chlorite matrix for the parenteral treatment of HIV infections. The chlorite matrix is an isotonic solution containing 5 to 100 mMol ClO2- per liter of solution.
109. Patent US5877222
Inhibiting tumor necrosis factor by administering stabilized, activated oxygen in chlorite matrix
Inventor:  Michael S. McGrath
Publication Date: 7/19/1996
Abstract:  The invention comprises inhibiting expression of TNF-α by administering an effective amount of a stabilized activated oxygen in a matrix of chlorite ions. Preferably, a pharmaceutically acceptable formulation of tetrachlorodecaoxide is used, and more preferably, WF-10. An effective amount of WF-10 comprises up to about 0.5 ml/kg. Another embodiment of the invention is a method of treating AIDS-associated dementia comprising the step of administering to a human an amount of a stabilized activated oxygen in a matrix of chlorite ions sufficient to inhibit production of TNF-α.
110. Patent US5252343
Infusing into mammary gland an isotonic solution of chlorine dioxide and carriers
Inventor:  Robert D. Kross
Publication Date:  10/12/1993
Abstract:  There is disclosed methods and compositions for preventing and treating bacterial infections, including mastitis, in the udder of a mammal. The compositions include chlorine dioxide in an amount ranging from 5 ppm to 1000 ppm, and have a chlorine dioxide to chlorite ratio of at least 5:1. Methods of the present invention include the infusion of the composition into the mammal’s udder, and the formation of the compositions immediately prior to infusion.


200. DioxiRinse161 DioxiRinse™ Mouthwash
201. 41H2wX7bnVL._SY355_1 DioxiBrite™ Toothpaste
202. Copy-of-DioxiWhiteHIRES-11 DioxiWhite™ Pro Teeth Whitener
203. Whitelasting1 WhiteLasting™ Maintenance Gel
204.  bioclenz_chlorine_dioxide_dental_unit_waterline_cleaner1 BioClenz™ Dental Unit Waterline Cleaner
 205. Penetrator_a3ca7814-b5cb-4a7a-a74c-7414a62a36c8_grande1 Penetrator™ Periodontal Gel
 206. simplyclear_grande1 Simply Clear™ Acne Treatment
207. dx7_skin_care_gel1 DX7™ Skin Protectant Gel
208. closys-rinse-200x1 CloSYS Oral Rinse™ Chlorine dioxide formula eliminates bad breath while fighting gingivitis and periodontitis.
209. nailit_grande1 Nail-It™ Nail Fungal Treatment
210. Firefight1 Fire Fighter™ Burn Pain Reliever
211. wp799b51bc_05_061 DioxiGuard 74™ Wound Spray